Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2000. Upgrade now.
Date Value
September 30, 2024 -1.514B
June 30, 2024 -2.872B
March 31, 2024 -2.413B
December 31, 2023 -1.077B
September 30, 2023 -1.221B
June 30, 2023 -520.00M
March 31, 2023 -1.246B
December 31, 2022 -249.00M
September 30, 2022 -1.743B
June 30, 2022 -800.00M
March 31, 2022 -168.00M
December 31, 2021 -913.00M
September 30, 2021 -10.46B
June 30, 2021 -236.00M
March 31, 2021 555.00M
December 31, 2020 138.00M
September 30, 2020 -580.00M
June 30, 2020 148.00M
March 31, 2020 9.00M
December 31, 2019 58.00M
September 30, 2019 74.00M
June 30, 2019 -1.117B
March 31, 2019 328.00M
December 31, 2018 927.00M
September 30, 2018 -141.00M
Date Value
June 30, 2018 -96.00M
March 31, 2018 273.00M
December 31, 2017 -1.642B
September 30, 2017 -335.00M
June 30, 2017 -205.00M
March 31, 2017 -146.00M
December 31, 2016 603.00M
September 30, 2016 -624.00M
June 30, 2016 -1.061B
March 31, 2016 -2.887B
December 31, 2015 -2.585B
September 30, 2015 -420.00M
June 30, 2015 -678.00M
March 31, 2015 -556.00M
December 31, 2014 -1.516B
September 30, 2014 -561.00M
June 30, 2014 -1.178B
March 31, 2014 -3.777B
December 31, 2013 -1.004B
September 30, 2013 -647.00M
June 30, 2013 -874.00M
March 31, 2013 -364.00M
December 31, 2012 -514.00M
September 30, 2012 -2.698B
June 30, 2012 760.00M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-10.46B
Minimum
Sep 2021
555.00M
Maximum
Mar 2021
-1.255B
Average
-690.00M
Median

Cash from Investing (Quarterly) Benchmarks

GSK PLC -926.64M
Amgen Inc -210.00M
Johnson & Johnson -3.128B
Sanofi SA --
Moderna Inc 721.00M